You just read:

Taiho Oncology, Inc. Announces Results from TAS-102 Global Phase III RECOURSE Trial in Refractory Metastatic Colorectal Cancer

News provided by

Taiho Oncology, Inc.

Jun 28, 2014, 06:30 ET